Healthcare and Life Science
Carterra Enables Anthropic's Autonomous AI Protein Design Study via its HT-SPR Binding Platforms
Carterra®, a leading provider of high-throughput surface plasmon resonance (HT-SPR) platforms for antibody and small molecule drug discovery, today highlighted the role of Carterra HT-SPR in one of the largest published wet-lab validations of AI-designed proteins to date. ...
Can a life sciences system be read without reference to its anchor?
By Lily Lin, CEO, Excellence First Enterprise Consultancy
Find My Place Coaching will be at the Cambridge Wellness Festival
Find My Place Coaching will be attending the Cambridge Wellness Festival on 8th September.The Cambridge Wellness Festival returns to the Cambridge Biomedical Campus to celebrate all things wellness. There is no charge for entry or for anything except refreshments – and as an added bonus...
Hospital visit inspires Cambridge businesses to take Cambridge’s 2027 Panda Meander fundraising to the next level
In March 2027, Cambridge's third Wild in Art sculpture trail will hit the streets of the University city. Attracting families and visitors from across the UK, and beyond, the trail has a special cause at the very heart of it - with funds going towards children's services at Addenbrooke'...
FairJourney Bio delivers antibody engineering for novel tumor-conditional IL-12 therapeutic approach that unlocks the potential of localized cytokine activation
Study in mAbs describes the first reported demonstration of a reversible trans-activation logic gate for tumor-conditional cytokine delivery FJBio engineered dual-specificity Fabs to meet model-defined affinity window through an end-to-end campaign across Porto and CambridgePorto, ...
Hidden drivers of aggressive childhood cancer revealed
New clues have been uncovered about why the childhood cancer, rhabdomyosarcoma, may behave aggressively. ...
Victory in sight in battle against blood virus
Clinicians from a specialist treatment hub at Addenbrooke’s Hospital believe the region is “on the home straight” in eradicating hepatitis C (HCV/HepC), a dangerous virus that attacks the liver. ...
Laura Tull shortlisted for Leader in Health & Safety Consultancy Award 2026
SHE does safety Director Laura Tull has been shortlisted for the Leader in Health & Safety Consultancy Award 2026, recognising an approach to consultancy built around practical, proportionate and genuinely useful health and safety support. ...
Qureight expands with addition of second site, to accommodate rapid growth and ongoing development of chest Foundation Model
Investment in new premises in London reflects significant milestone in Company’s growth, following $20 million Series B financingSupports rapid scale-up and development of foundational AI imaging model, to improve clinical trial design across broader range of chest diseasesCambridge, UK...
Why Antibody-Oligonucleotide Conjugates Are Gaining Momentum
Therapeutic oligonucleotides offer sequence-selective, programmable ways to modulate disease biology, but reaching the right cells outside the liver remains a persistent barrier. This blog introduces AOCs as a strategy for extending targeted delivery to skeletal muscle, heart and brain,...